The ongoing COVID-19 pandemic in India is likely to exacerbate pressure on the country's non-life insurers' underwriting and investment performance, leading AM Best to maintain its negative outlook on this market segment.
If you are already a subscriber
OR sign-up for a trial access here
Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.
Brought to you by